Although there is no cure for Devic's disease (neuromyelitis optica), it can enter a long indolent period in which the disease essentially does not progress. This is the best hoped-for outcome for Devic's disease.
It is still controversial whether Devic syndrome is a variant of multiple sclerosis.
The prognosis for recovery of temporomandibular joint syndrome (TMJ) is excellent for almost all patients because surgical procedures are almost always successful.
With quick identification of the syndrome and immediate supportive treatment, the majority of patients recover fully, although mortality rates are still significant.
This occurs due to degeneration of the nerves that exit the spinal cord and serve the body's trunk and limbs.
The prognosis for complete recovery is good for most patients, except those with hyperinfection syndrome or severe protein loss.
There is no cure available for Devic syndrome. Treatment, therefore, is based solely on lessening the symptoms and providing comfort care for individuals that are in the more advanced stages of the disease.
Most patients recover in three to four months, but about 50% have recurrences for several years. Some patients develop complications
The prognosis for TGA patients is excellent
Most patients with Kawasaki syndrome will recover completely, but about 1-2% will die as a result of blood clots forming in the coronary arteries or as a result of a heart attack. Deaths are sudden and unpredictable
Devic syndrome is a chronic and degenerative disorder that usually affects both eyes. The eyes develop diminished sensitivity to bright lights, color vision impairment, and diminished light reflexes.
There is no cure for SPS and the long-term prognosis is variable. Many patients have a slow course of the disorder that is mostly without symptoms, punctuated by occasional episodes of stiffness.
The prognosis for males diagnosed with Wiskott-Adrich syndrome is poor.